Skip to main content
Grey Wolf Animal Health Corp. logo

Grey Wolf Animal Health Corp. — Investor Relations & Filings

Ticker · WOLF ISIN · CA3978851044 TSXV Manufacturing
Open in API
Filings indexed 108 across all filing types
Latest filing 2026-04-17 Earnings Release
Country CA Canada
Listing TSXV WOLF

About Grey Wolf Animal Health Corp.

https://greywolfah.com/

Grey Wolf Animal Health Corp. is a specialty animal health and wellness company focused on improving the lives and well-being of animals, including pets and horses, by empowering veterinary professionals and owners with innovative solutions. The company operates in the animal health market, developing and commercializing products that address unmet needs. Key offerings include prescription injectables (such as Ataject™ and Sedaject™), advanced wound care products (like Activon® Tube, featuring medical-grade Manuka Honey), all-natural gastrointestinal treatments (GI™ Portfolio), and vet-exclusive nutraceuticals (Composure™ Pro). Furthermore, through its compounding pharmacy, Trutina, the company provides specialized custom formulations, particularly for the equine market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release dated April 16, 2026 announcing fourth quarter and full-year 2025 financial results, including key highlights, summary tables of revenue, EBITDA, and net income, as well as brief commentary from the CEO. It is not the full management discussion and analysis or audited financial statements but rather the initial earnings announcement for the period. Therefore, it matches the Earnings Release category (ER). FY 2025
2026-04-17 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release announcing the company’s financial results for the fourth quarter and full fiscal year ended December 31, 2025. It includes key highlights, summary tables of revenue, profit, EBITDA and basic discussion of operations, typical of an initial earnings announcement rather than a full interim/quarterly report (IR) or an annual report (10-K). Therefore, this fits the Earnings Release category. FY 2025
2026-04-17 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-501F1 filed with the Alberta Securities Commission to calculate and certify a participation fee based on the issuer’s market values. This is a regulatory compliance filing rather than an annual report, earnings release, or management presentation. It therefore falls under the general Regulatory Filings category (RNS).
2026-04-16 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1 submission to the Ontario Securities Commission detailing participation fee calculations for a reporting issuer. It is a regulatory fee filing rather than an annual report, earnings release, proxy statement, or other specific corporate action. It falls into the catch-all category for miscellaneous regulatory filings.
2026-04-16 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 venture issuer basic certificate signed by the CEO certifying the review and fair presentation of annual filings under Canadian NI 52-109. It is not the annual report itself, nor an announcement of its publication, but a regulatory certification filing. This falls under the general Regulatory Filings category (RNS).
2026-04-16 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Venture Issuer Basic Certificate filed by the CFO certifying the annual filings. It is not the actual Annual Report (10-K), Audit Report, or MD&A itself, nor is it an announcement of earnings or dividends. It is a regulatory compliance filing under Canadian securities legislation, and no more specific category applies. Therefore it falls into the fallback category of general Regulatory Filings (RNS).
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.